The Latest Cardiac and Vascular News
Coverage policy improves access to artificial intelligence-enabled plaque analysis providing insights to help physicians guide treatment decisions for patients with coronary artery disease Coverage policy improves access to artificial intelligence-enabled plaque analysis providing insights to help physicians guide treatment decisions for patients with coronary artery disease
Tricuspid valve regurgitation can lead to enlarged heart, fatigue and heart failure; the condition affects 1.6 million Americans PITTSBURGH, Oct. 10, 2024 /PRNewswire-PRWeb/ — The cardiac team from Allegheny General Hospital (AGH), the academic flagship facility of Allegheny Health…
Enrollment completed ahead of schedule in the global IDE for Abbott’s Volt™ PFA System Global FOCALFLEX trial now underway for Abbott’s TactiFlex™ Duo Ablation Catheter, Sensor Enabled™ Advisor™ HD Grid X Mapping Catheter, Sensor Enabled™, receives U.S. Food and Drug Administration…
Campaign is led by prominent medical societies to minimize discrepancies in treating blood clot conditions, such as in pulmonary embolism, where there are often delays in care (up to 26% of patients in one study) and misdiagnosis (up to 53% of patients in one study)1,2 ALAMEDA, Calif.,…
OKLAHOMA CITY, Oct. 9, 2024 /PRNewswire/ — OU Health, the flagship academic health system of the University of Oklahoma, has performed its first pediatric heart transplant in decades at Oklahoma Children’s Hospital OU Health, marking a significant milestone in pediatric cardiac care for…
Medtronic plc, a global leader in healthcare technology, today announced the launch of the Avalus Ultra™ Bioprosthesis valve in Western Europe during the EACTS annual congress in Lisbon. The Avalus Ultra valve, engineered for ease of use at implant and lifetime patient management, is Medtronic’s most advanced surgical aortic tissue […]
MOUNTAIN VIEW, Calif., Oct. 8, 2024 /PRNewswire/ — The radiology department of Louis Stokes Cleveland VA Medical Center (LSCVAMC) has chosen HealthLevel’s radiology business operations platform, Foundations™, to enhance patient care and boost the operational efficiency of its clinical…
NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) — E-Star BioTech, LLC (“E-Star” or the “Company”), an innovative developer of novel peptides designed to treat cardiovascular, metabolic, and kidney diseases, today announced that it is set to initiate a Phase 2 clinical trial of MANP for the treatment of Resistant Hypertension (BOLD-HTN) supported by a recent round of financing.
Medical device company marks trial milestone in the evaluation of its embolic protection device, creates expert advisory board as it navigates growth opportunity TAMPA, Fla., Oct. 8, 2024 /PRNewswire/ — EMBLOK™ (emblok.com), a privately held medical device company developing the most…
HENRICO, Va. and RALEIGH, N.C., Oct. 8, 2024 /PRNewswire/ — Compass Surgical Partners, Bon Secours Mercy Health and AlignedCardio today announced their plans to open Short Pump Cardiovascular Ambulatory Surgery Center in the Short Pump area of Henrico, Virginia. Scheduled to open in late…
